These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 1825636)
1. Murine tumor cells expressing the gene for the human interferon alpha beta receptor elicit antibodies in syngeneic mice to the active form of the receptor. Uzé G; Lutfalla G; Eid P; Maury C; Bandu MT; Gresser I; Mogensen K Eur J Immunol; 1991 Feb; 21(2):447-51. PubMed ID: 1825636 [TBL] [Abstract][Full Text] [Related]
2. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. Wietzerbin J; Gaudelet C; Aguet M; Falcoff E J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825 [TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor. Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the human type I interferon receptor by ligand blotting. Schwabe M; Princler GL; Faltynek CR Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600 [TBL] [Abstract][Full Text] [Related]
5. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955 [TBL] [Abstract][Full Text] [Related]
6. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]
7. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon. Gomi K; Akinaga S; Oka T; Morimoto M Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo. Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells. Dunne SL; Bajzer Z; Vuk-Pavlović S Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259 [TBL] [Abstract][Full Text] [Related]
10. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells. Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700 [TBL] [Abstract][Full Text] [Related]
11. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor. Sheehan KC; Calderon J; Schreiber RD J Immunol; 1988 Jun; 140(12):4231-7. PubMed ID: 2453573 [TBL] [Abstract][Full Text] [Related]
13. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site. Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126 [TBL] [Abstract][Full Text] [Related]
14. Interferon-induced transfer of natural cytotoxic activity between human leukocytes. Weigent DA; Blalock JE; Stanton GJ J Biol Response Mod; 1985 Feb; 4(1):60-9. PubMed ID: 2580063 [TBL] [Abstract][Full Text] [Related]
15. Domains of interaction between alpha interferon and its receptor components. Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753 [TBL] [Abstract][Full Text] [Related]
16. Expression of a binding structure for sialic acid-containing glycoconjugates on rat bone marrow-derived macrophages and its modulation by IFN, TNF-alpha, and dexamethasone. Gessl A; Boltz-Nitulescu G; Wiltschke C; Holzinger C; Nemet H; Pernerstorfer T; Förster O J Immunol; 1989 Jun; 142(12):4372-7. PubMed ID: 2470823 [TBL] [Abstract][Full Text] [Related]
17. Localization of the receptor binding site of IFN-alpha 2b. Siemers R; Hensley L; Ozer H J Immunol; 1988 Sep; 141(5):1550-5. PubMed ID: 2970505 [TBL] [Abstract][Full Text] [Related]
18. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression. Greiner JW; Fisher PB; Pestka S; Schlom J Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575 [TBL] [Abstract][Full Text] [Related]
20. [Receptor system of interferons]. Yonehara S Gan To Kagaku Ryoho; 1984 Jan; 11(1):44-52. PubMed ID: 6320747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]